Company: NGVT
Filing Date: 2025-11-06
Form Type: 10-Q
Source: 0001653477-25-000127
Chunk: 157

Company: Ingevity Corp
Filing Date: 2025-11-06
Form: 10-Q
Item: Part I, Item 2
Chunk 157
---
 the three and nine months ended September 30, 2025, and $(0.1) million and zero for the three and nine months ended September 30, 2024, respectively. All charges relate to the integration of Ozark Materials into our Performance Chemicals reportable segment. 

Other (income) expense, net

Three and Nine Months Ended September 30, 2025 vs. 2024Three Months Ended September 30,Nine Months Ended September 30,In millions2025202420252024Foreign currency transaction (gain) loss $0.2 $1.0 $(1.3)$3.1 (Gain) loss on strategic investments (1)— 2.2 2.5 2.1 CEO severance charges— 4.8 — 4.8 Proxy contest charges (2)— — 8.2 — Portfolio review expenses (2)1.1 — 1.1 — Other (income) expense, net(0.1)(1.5)(1.0)(2.2)Total Other (income) expense, net$1.2 $6.5 $9.5 $7.8 _______________

(1) See Note 4 for more information.

(2) See Note 14 for more information.

39

Interest expense, net

Three and Nine Months Ended September 30, 2025 vs. 2024

Three Months Ended September 30,Nine Months Ended September 30,In millions2025202420252024Accounts receivable securitization (1)$1.3 $1.7 $3.1 $4.5 Finance lease obligations (1)1.8 1.8 5.4 5.4 Interest rate swap (2)(0.2)(0.4)(0.7)(0.4)Litigation related interest expense (3)1.4 1.3 3.9 3.9 Revolving Credit Facility and other lines of credit (1)9.5 14.5 31.2 41.7 Senior notes (1)5.6 5.6 16.8 16.8 Other interest (income) expense, net(1.0)(0.7)(3.3)(2.6)Total Interest expense, net$18.4 $23